1 Growth Stock Set to Skyrocket in 2026 and Beyond

A growth stock is a stock in a company that is expected to grow at a faster rate than the market. These stocks typically trade at what looks like expensive valuations, and they are typically volatile and do not pay dividends.

In this article, I’ll review a growth stock that continues to grow rapidly, while driving cash flows and earnings higher.

What is this growth stock all about?

Well Health Technologies Corp. (TSX:WELL) is an omnichannel digital healthcare company, with a network that includes primary, specialized, and diagnostic healthcare services and facilities.

In the five years ended 2024, Well Health Technologies has grown at a rapid pace. Revenue increased more than 1,700% to $919 million. And adjusted net income increased to $32 million from a loss of almost $4 million. Finally, earnings per share (EPS) increased to $0.13, up from net losses in 2020.

In the last year, Well Health’s stock price has declined more than 20%. Yet, the company continued to grow rapidly in the first nine months of 2025. During this time period, revenue increased 48% to just over $1 billion, and adjusted net income increased almost 200% to $75 million.

Well Health – Driving cash flows

Today, the company’s strategy is to simplify and focus. This means divesting of its US assets, and focusing on the Canadian business. To this end, Well Health will complete a strategic alternatives process for its US care delivery business in 2026.

This will simplify the business and free up capital to be invested in the higher-growth Canadian businesses. The cash flows received from this process will complement the cash flows that Well Health is generating on a quarterly basis.

In the last three quarters of 2025, Well Health reported positive operating cash flow excluding changes in working capital of $110 million. In the third quarter, Well Health’s free cash flow came in at approximately $39 million. This is not a given with companies that are in the rapid growth phase. We can expect cash flows to continue to ramp up as Well Health continues to drive growth and increase its focus on the Canadian business.

Valuation

A growth stock is usually not cheap based on current earnings numbers. But based on adjusted earnings expectations for 2025, Well Health’s valuation actually looks quite attractive. Trading at 10 times adjusted earnings, Well Health’s stock price on the TSX is clearly not giving the company credit for its successful execution and financials.

This lack of recognition by investors is understandable in a sense, as there’s uncertainty related to Well Health’s efforts to monetize its US businesses. The company could get less than it’s expecting, and nothing is certain until a deal is finalized. But this is the opportunity. If Well Health continues along its rapid growth trajectory, the company will continue to thrive well into the future.

The bottom line

Well Health stock on the TSX is a growth stock to consider adding as it’s set to gain momentum in 2026 and beyond. It’s a big year – if Well Health can finalize its strategic divestitures in 2026, the risk premium on the stock will decline significantly, thus driving Well Health’s stock price higher.

The post 1 Growth Stock Set to Skyrocket in 2026 and Beyond appeared first on The Motley Fool Canada.

Should you invest $1,000 in WELL Health Technologies Corp. right now?

Before you buy stock in WELL Health Technologies Corp., consider this:

The Motley Fool Canada team has identified what they believe are the top 10 TSX stocks for 2026… and WELL Health Technologies Corp. wasn’t one of them. The 10 stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 … if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,155.76!*

Now, it’s worth noting Stock Advisor Canada’s total average return is 90%* – a market-crushing outperformance compared to 81%* for the S&P/TSX Composite Index. Don’t miss out on our top 10 stocks, available when you join our mailing list!

Get the 10 stocks instantly #start_btn6 { background: #0e6d04 none repeat scroll 0 0; color: #fff; font-size: 1.2em; font-family: 'Montserrat', sans-serif; font-weight: 600; height: auto; line-height: 1.2em; margin: 30px 0; max-width: 350px; text-align: center; width: auto; box-shadow: 0 1px 0 rgba(0, 0, 0, 0.5), 0 1px 0 #fff inset, 0 0 2px rgba(0, 0, 0, 0.2); border-radius: 5px; } #start_btn6 a { color: #fff; display: block; padding: 20px; padding-right:1em; padding-left:1em; } #start_btn6 a:hover { background: #FFE300 none repeat scroll 0 0; color: #000; } @media (max-width: 480px) { div#start_btn6 { font-size:1.1em; max-width: 320px;} } margin_bottom_5 { margin-bottom:5px; } margin_top_10 { margin-top:10px; }

* Returns as of February 17th, 2026

More reading

• 3 Canadian Growth Stocks I’d Add to Any TFSA in 2026
• 2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
• 3 Undervalued TSX Stocks That Could Surprise Investors in 2026
• 1 Canadian Stock Ready to Rocket Through 2026

Fool contributor Karen Thomas has a position in Well Health Technologies. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.